Can the Prophylactic Use of Raloxifene, a Selective Estrogen-Receptor Modulator, Prevent Bone Mineral Loss and Fractures in Women With Diagnosed Osteoporosis or Vertebral Fractures?
Western Journal of Medicine
doi 10.1136/ewjm.173.3.186-a
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2000
Authors
Publisher
BMJ